Clinical Trial Update: Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis

View source ↗

Summary

This completed trial update presents age-stratified results of upadacitinib for refractory inflammatory bowel disease in Asian children and the elderly. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn's Disease (CD), Ulcerative Colitis (UC) | Status: COMPLETED